Business Description
Oncolys BioPharma Inc
ISIN : JP3202170001
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 4.86 | |||||
Equity-to-Asset | 0.72 | |||||
Debt-to-Equity | 0.21 | |||||
Debt-to-EBITDA | -0.16 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | 10.62 | |||||
Beneish M-Score | -1.36 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -45.5 | |||||
3-Year EBITDA Growth Rate | 9.2 | |||||
3-Year EPS without NRI Growth Rate | 5.5 | |||||
3-Year FCF Growth Rate | 9.6 | |||||
3-Year Book Growth Rate | -18.2 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 56.59 | |||||
9-Day RSI | 54.97 | |||||
14-Day RSI | 55.26 | |||||
6-1 Month Momentum % | 21.06 | |||||
12-1 Month Momentum % | 10.86 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 5.17 | |||||
Quick Ratio | 5.15 | |||||
Cash Ratio | 4.05 | |||||
Days Inventory | 131.73 | |||||
Days Sales Outstanding | 640.01 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -10.3 | |||||
Shareholder Yield % | 0.64 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 48.55 | |||||
Operating Margin % | -3061.63 | |||||
Net Margin % | -3075.14 | |||||
FCF Margin % | -2129.84 | |||||
ROE % | -119.94 | |||||
ROA % | -91.31 | |||||
ROIC % | -334.97 | |||||
ROC (Joel Greenblatt) % | -476.08 | |||||
ROCE % | -107.54 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 193.96 | |||||
PB Ratio | 9.4 | |||||
Price-to-Tangible-Book | 9.4 | |||||
EV-to-EBIT | -6.75 | |||||
EV-to-EBITDA | -6.75 | |||||
EV-to-Revenue | 206.85 | |||||
EV-to-FCF | -9.71 | |||||
Price-to-Median-PS-Value | 4.75 | |||||
Price-to-Net-Current-Asset-Value | 9.97 | |||||
Price-to-Net-Cash | 14.34 | |||||
Earnings Yield (Greenblatt) % | -14.81 | |||||
FCF Yield % | -9.42 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Oncolys BioPharma Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil 円) | 63.038 | ||
EPS (TTM) (円) | -108.92 | ||
Beta | 0.93 | ||
Volatility % | 53.15 | ||
14-Day RSI | 55.26 | ||
14-Day ATR (円) | 31.961973 | ||
20-Day SMA (円) | 695.3 | ||
12-1 Month Momentum % | 10.86 | ||
52-Week Range (円) | 504 - 798 | ||
Shares Outstanding (Mil) | 20.19 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Oncolys BioPharma Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Oncolys BioPharma Inc Stock Events
Event | Date | Price(円) | ||
---|---|---|---|---|
No Event Data |
Oncolys BioPharma Inc Frequently Asked Questions
What is Oncolys BioPharma Inc(TSE:4588)'s stock price today?
When is next earnings date of Oncolys BioPharma Inc(TSE:4588)?
Does Oncolys BioPharma Inc(TSE:4588) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |